| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 02/18/2010 | US20100041889 Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv |
| 02/18/2010 | US20100041711 Urea Glucokinase Activators |
| 02/18/2010 | US20100041708 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for it's preparation |
| 02/18/2010 | US20100041707 Inhibitors of ion channels |
| 02/18/2010 | US20100041700 Substituted 1-(Azolin-2-yl)-Amino-1,2-Heterocyclyl-Ethane Compounds For Combating Pests |
| 02/18/2010 | US20100041660 Novel 2-pyridinecarboxamide derivatives |
| 02/18/2010 | US20100041656 Novel amide derivatives and medicinal use thereof |
| 02/18/2010 | US20100041649 viricides used for for treating a human papillomavirus (HPV) viral infections, for inhibiting HPV DNA replication or for preventing prenatal transmission of HPV from mother to baby by administering to the mother prior to giving birth |
| 02/18/2010 | US20100041645 Rho kinase inhibitors |
| 02/18/2010 | US20100041555 3-Phenoxy-4-pyridazinol derivatives and herbicidal composition containing the same |
| 02/18/2010 | CA2733966A1 Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators |
| 02/18/2010 | CA2733397A1 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 02/18/2010 | CA2731102A1 Imine derivatives as cannabinoid receptor ligands |
| 02/17/2010 | EP2153832A2 Heterocyclic aspartyl protease inhibitors |
| 02/17/2010 | EP2152717A1 Processes for making epothilone compounds and analogs |
| 02/17/2010 | EP2152702A1 Amino-thiazolyl- pyrimidine derivatives and their use for the treatment of cancer |
| 02/17/2010 | EP2152701A1 Phenyl amino pyrimidine compounds and uses thereof |
| 02/17/2010 | EP2152700A1 Csf-1r inhibitors, compositions, and methods of use |
| 02/17/2010 | EP2152696A1 Aminopyrimidines useful as kinase inhibitors |
| 02/17/2010 | EP2152694A2 Thiazoles and pyrazoles useful as kinase inhibitors |
| 02/17/2010 | EP2152690A1 Pyridyl piperidine orexin receptor antagonists |
| 02/17/2010 | EP2152688A1 Compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 02/17/2010 | EP2152674A1 Benzimidazolone chymase inhibitors |
| 02/17/2010 | EP2152664A1 Dipeptide analogs as coagulation factor inhibitors |
| 02/17/2010 | EP1902026B1 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm) |
| 02/17/2010 | EP1773827B1 Benzothiazole derivatives |
| 02/17/2010 | EP1549318B1 Crystal structure of aurora-2 protein and binding pockets thereof |
| 02/17/2010 | EP1377263B1 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic diazo dye |
| 02/17/2010 | CN101652363A Thiazolyl compounds useful as kinase inhibitors |
| 02/17/2010 | CN101652362A Method for producing epothilone derivatives by means of selective catalytic epoxidation |
| 02/17/2010 | CN101648949A inhibitors of phosphatidylinositol 3-kinase |
| 02/17/2010 | CN101648944A 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 02/17/2010 | CN100590123C 2,4-disubstituted thiazolines derivatives, preparing method and application thereof |
| 02/16/2010 | US7662972 Insecticidal and acaricidal activity for many agricultural insect pests, spider mites; endo- or ecto-parasiticide for mammals or birds; veterinary medicine; environmentally friendly |
| 02/16/2010 | US7662971 enzyme inhibitor for treating sleep disorders |
| 02/16/2010 | US7662958 e.g. N-[3-{1-[(cyclobutyl)amino]-4-hydroxy-2-oxo-1,2-dihydro-quinolin -3-yl}-1,1-dioxo-1,4-dihydro-1 lambda 6-thieno[2,3-e][1,2,4]thiadiazin-7-yl)methyl]methane-sulfonamide; viricides for infections caused by an RNA-containing virus; hepatitis C virus (HCV) polymerase inhibitor; liver cirrhosis |
| 02/16/2010 | US7662849 N-cyanomethyl-2R-[(benzenesulfonyliminomethyl)amino]-3-(2-difluoromethoxyphenylmethanesulfonyl)-propionamide; treating autoimmune disorders |
| 02/16/2010 | US7662847 Myelodysplastic syndrome, Parkinson*s disease, multiple sclerosis, AIDS, chronic obstructive pulmonary disease, acquired respiratory distress; analgesics, angiogenesis inhibitors; anticarcinogenic and antitumor agents; phopshodiesterase, tumor necrosis factor and matrix metalloproteinase inhibitors |
| 02/16/2010 | US7662842 (4R)-2-(4-methoxyphenyl)-N-octadecylthiazolidine-4-carboxamide; antiacarcinogenic agent for destroying a melanoma cell |
| 02/16/2010 | US7662839 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders; e.g. {4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl}-acetic acid |
| 02/16/2010 | US7662834 Methods of 1H-indol-3-yl-2-oxoacetamide compounds |
| 02/16/2010 | US7662818 e.g. 4-[5-(piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; and multiple sclerosis |
| 02/16/2010 | US7662811 1,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of use |
| 02/16/2010 | CA2628224C Vinyl-pyrrolidinone cephalosporins with basic substituents |
| 02/16/2010 | CA2571627C Substituted aryl-amine derivatives and methods of use |
| 02/16/2010 | CA2479274C Thiazolidinedione derivatives and pharmaceutical composition comprising the same |
| 02/16/2010 | CA2450922C Piperidines for use as orexin receptor antagonists |
| 02/16/2010 | CA2385938C Cyclic amine compounds as ccr5 antagonists |
| 02/16/2010 | CA2385081C Carboxylic acid compound and a medicament comprising it |
| 02/16/2010 | CA2343883C An improved process for the preparation of thiazolidine-2,4-dione derivatives |
| 02/11/2010 | WO2010017350A1 Aminopyridine kinase inhibitors |
| 02/11/2010 | WO2010017079A1 Oxazole derivatives useful as inhibitors of faah |
| 02/11/2010 | WO2010016612A1 Dye for dye-sensitized solar cell, semiconductor electrode, and dye-sensitized solar cell |
| 02/11/2010 | WO2010015792A1 Nitrogen containing heterocyclic compounds useful as bifunctional modulators of m3 receptors and beta-2 receptors |
| 02/11/2010 | WO2010015681A1 Fungicidal n-(2-pyridylpropyl)carboxamide derivatives and their oxa, aza and thia analogues |
| 02/11/2010 | WO2010015652A2 Thiazole compounds as activators of soluble guanylate cyclase |
| 02/11/2010 | WO2010015090A1 Functionalized pyrrolidines and use thereof as iap inhibitors |
| 02/11/2010 | US20100036118 Fused Ring Heterocycle Kinase Modulators |
| 02/11/2010 | US20100035929 Unnatural dispyrin analogues, preparation and uses thereof |
| 02/11/2010 | US20100035899 5,7-DISUBSTITUTED[1.3]THIAZOLO[4,5-d]PYRIMIDIN-2(3H)-AMINE DERIVATIVES AND THEIR USE IN THERAPY |
| 02/11/2010 | US20100035869 Targeted nitroxide agents |
| 02/11/2010 | US20100035858 Novel Compositions and Methods for Binding and Inhibiting 5-HT4 Receptor |
| 02/11/2010 | US20100034813 Substituted pyrazole and triazole compounds as ksp inhibitors |
| 02/11/2010 | US20100032658 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 02/11/2010 | CA2732765A1 Aminopyridine kinase inhibitors |
| 02/11/2010 | CA2732526A1 Oxazole derivatives useful as inhibitors of faah |
| 02/10/2010 | EP2151438A1 Pharmaceutical containing ppar agonist |
| 02/10/2010 | EP2151435A1 Pharmaceutical composition for treatment of alzheimer's disease |
| 02/10/2010 | EP2150546A2 Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase |
| 02/10/2010 | EP2150539A1 Pyridazinone derivatives |
| 02/10/2010 | EP2150255A1 Quinoxaline derivatives as p13 kinase inhibitors |
| 02/10/2010 | EP2150115A1 Cyclopropyl pyrrolidine orexin receptor antagonists |
| 02/10/2010 | EP2086965B1 Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases |
| 02/10/2010 | EP1817287B1 Aromatic ether derivatives useful as thrombin inhibitors |
| 02/10/2010 | EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/10/2010 | EP1411932B1 Substituted oxazolidinones for combinational therapy |
| 02/09/2010 | US7659405 Protease inhibitor; viricides; purity; crystal structure; mixing tank |
| 02/09/2010 | US7659404 Broad spectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors |
| 02/09/2010 | US7659399 1-thia-2,4a-diaza-cyclopenta[b]napththalene-3,4-diones and related compounds as anti-infective agents |
| 02/09/2010 | US7659394 Substituted morpholine compounds for the treatment of central nervous system disorders |
| 02/09/2010 | US7659307 Heterocyclic carboxamides and their use as fungicides |
| 02/09/2010 | US7659298 2-(3-Phenyl-5-chloro-1-methyl-1H-pyrazol-4-ylmethylsulphanyl)-N-quinolin-3-ylbenzamide; 2-(3-Phenyl-5-chloro-1-methyl-1H-pyrazol-4-ylmethoxy)-N-naphthalin-2-ylbenzamide; obesity, including obesity of the non-insuline-dependent diabetes patients, sleeping disorders, stroke, nausea and vomiting |
| 02/09/2010 | US7659296 2-{1-[4-(3,3-dimethyl-2-oxo-butoxy)-3-methyl-phenyl]-1-ethyl-propyl}-benzooxazole-6-carboxylic acid; 1-[4-(3,3-Dimethyl-2-oxo-butoxy)-3-methyl-phenyl]-1-ethyl-propyl}-benzooxazole-6-carboxylic acid amide; stimulate bone formation, restore bone quality, acne, alopecia, Alzheimer's disease etc. |
| 02/09/2010 | US7659280 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases |
| 02/09/2010 | US7659269 Substituted indolealkanoic acids |
| 02/09/2010 | US7659266 N1-[(3S)-2-hydroxytetrahydrofuran-3-yl]-N2-[imino(10H-phenothiazin-2-yl)methyl]-L-leucinamide; (3S)-3-({N-[imino(10H-phenothiazin-2-yl)methyl]-L-leucyl}amino)tetrahydrofuran-2-yl acetate; hearing disorders, muscular dystrophy |
| 02/09/2010 | US7659265 5-(4,4-dimethyl-2-thioxo-1,4-dihydro-2H-3,1-benzoxazin-6-yl)-1-methyl-1H-pyrrole-2-carbothioamide; menopause therapy; contraceptive; anticancer agents |
| 02/09/2010 | CA2484954C 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 02/09/2010 | CA2413061C Serine protease inhibitors |
| 02/09/2010 | CA2291065C Raf kinase inhibitors |
| 02/09/2010 | CA2274201C Di-or triaza-spiro[4,5]decane derivatives |
| 02/04/2010 | WO2010014611A1 Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds |
| 02/04/2010 | WO2010014240A2 Novel bioactive small molecules derived from sea sponges |
| 02/04/2010 | WO2010013769A1 Crystal of thiazolidinedione compound, and process for production thereof |
| 02/04/2010 | WO2010013768A1 Crystal of thiazolidinedione compound, and process for production thereof |
| 02/04/2010 | WO2010013595A1 (5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative |
| 02/04/2010 | WO2010013222A1 Pyrrole carboxylic acid derivatives as antibacterial agents |
| 02/04/2010 | WO2010013161A1 Fluorinated heteroaryls |
| 02/04/2010 | WO2010013078A2 Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as ccr3 receptor ligands |
| 02/04/2010 | WO2010013037A1 1,2,4-oxadiazole substituted piperidine and piperazine derivatives as smo antagonists |